

————————————————————————————————————————————————————————————————————————————————————————————————————
                                                                              A               B    
                                                                           N     E         N     E 
————————————————————————————————————————————————————————————————————————————————————————————————————
                                                                                                   
Number of subjects                                                       28              46        
                                                                                                   
Total exposure                                                           12.76           22.61     
                                                                                                   
Infections and infestations                                              11    17.5      16    21.5
                                                                                                   
Gastrointestinal disorders                                                9    14.5       8    13.5
                                                                                                   
Musculoskeletal and connective tissue disorders                           6     9.5       4     4.5
                                                                                                   
Renal and urinary disorders                                               1     1.5       6     8.5
                                                                                                   
General disorders and administration site conditions                      3     3.5       3     7.5
                                                                                                   
Investigations                                                            3     4.5       6     7.5
                                                                                                   
Respiratory, thoracic and mediastinal disorders                           2     2.5       6     6.5
                                                                                                   
Eye disorders                                                                             5     5.5
                                                                                                   
Injury, poisoning and procedural complications                            3     4.5       2     4.5
                                                                                                   
Nervous system disorders                                                  1     2.5       4     4.5
                                                                                                   
Blood and lymphatic system disorders                                      2     2.5       3     3.5
                                                                                                   
Hepatobiliary disorders                                                                   2     3.5
                                                                                                   
Immune system disorders                                                   2     2.5       1     1.5
                                                                                                   
Metabolism and nutrition disorders                                        2     2.5       1     1.5
                                                                                                   
Skin and subcutaneous tissue disorders                                    1     1.5       2     2.5
                                                                                                   
Cardiac disorders                                                         1     1.5       1     1.5
                                                                                                   
Ear and labyrinth disorders                                                               1     1.5
                                                                                                   
Endocrine disorders                                                                       1     1.5
                                                                                                   
Neoplasms benign, malignant and unspecified (incl cysts and polyps)                       1     1.5
                                                                                                   
Vascular disorders                                                        1     1.5       1     1.5
————————————————————————————————————————————————————————————————————————————————————————————————————



